Page last updated: 2024-10-22

amifostine anhydrous and Salivary Gland Diseases

amifostine anhydrous has been researched along with Salivary Gland Diseases in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Salivary Gland Diseases: Diseases involving the SALIVARY GLANDS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riley, P1
Glenny, AM1
Hua, F1
Worthington, HV1
Mandel, SJ1
Mandel, L1

Reviews

2 reviews available for amifostine anhydrous and Salivary Gland Diseases

ArticleYear
Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
    The Cochrane database of systematic reviews, 2017, 07-31, Volume: 7

    Topics: Amifostine; Drugs, Chinese Herbal; Female; Fibroblast Growth Factor 7; Humans; Male; Pilocarpine; Qu

2017
Radioactive iodine and the salivary glands.
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:3

    Topics: Amifostine; Carcinoma, Papillary; Humans; Iodine Radioisotopes; Radiation Injuries; Radiation-Protec

2003